Recent advances in incretin-based therapies.
The global burden of type 2 diabetes is growing. Traditional therapies are suboptimal and there is a clear unmet need for treatments that offer effective glucose control while addressing the comorbid factors associated with diabetes, such as obesity and risk of cardiovascular disease, without the fe...
Main Authors: | Russell-Jones, D, Gough, S |
---|---|
Format: | Journal article |
Language: | English |
Published: |
2012
|
Similar Items
-
Incretin-based therapy: renal effects
by: Anton Ivanovich Korbut, et al.
Published: (2016-01-01) -
Expert committee on introduction of incretin-based therapy in Russia: advance and failure
by: Editorial team Diabetes Mellitus
Published: (2012-09-01) -
Incretins in the Therapy of Diabetic Kidney Disease
by: Agnieszka Przezak, et al.
Published: (2021-11-01) -
Achieving glycaemic control and weight loss with incretin-based therapies: a comparison of liraglutide, exenatide, and sitagliptin
by: Zinman, B, et al.
Published: (2011) -
Extrapancreatic actions of incretin-based therapies on bone in diabetes mellitus
by: Mansur, Sity Aishah
Published: (2015)